Publications by authors named "Piotr Jaskiewicz"

Claim this Profile
V
Venous thromboembolism is associated with increased all-cause mortality in ALK-positive non-small cell lung cancer.
Magdalena Zaborowska-Szmit, Sebastian Szmit, Marta Olszyna-Serementa, Katarzyna Zajda, Anna Janowicz-Żebrowska

Cardiooncology· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Detailed Analysis of Polish Patients with Non-Small Cell Lung Cancer Through Insights from Molecular Testing (POL-MOL Study).
Dariusz M Kowalski, Magdalena Zaborowska-Szmit, Maciej Bryl, Agnieszka Byszek, Dariusz Adam Dziedzic

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of osimertinib and savolitinib as molecular inhibition of EGFR and MET receptors may be selected to provide maximum effectiveness and acceptable toxicity.
Dariusz M Kowalski, Magdalena Zaborowska-Szmit, Sebastian Szmit, Piotr Jaśkiewicz, Maciej Krzakowski

Transl Lung Cancer Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer.
Marta Olszyna-Serementa, Magdalena Zaborowska-Szmit, Sebastian Szmit, Piotr Jaśkiewicz, Katarzyna Zajda

Curr Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy.
Magdalena Zaborowska-Szmit, Sebastian Szmit, Marta Olszyna-Serementa, Paweł Badurak, Katarzyna Zajda

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of adenoid cystic carcinoma of trachea: treatment complications and radiotherapy role.
Aleksandra Piórek, Sylwia Tabor, Piotr Jaśkiewicz, Anetta Kasprowicz, Magdalena Zaborowska-Szmit

J Contemp Brachytherapy· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03).
Francesco Grossi, Piotr Jaśkiewicz, Marion Ferreira, Grzegorz Czyżewicz, Dariusz Kowalski

Ther Adv Med Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two neoplasms rich in small lymphocytes, B1B2 thymoma and small lymphocytic lymphoma, intermingled in one tumor mass. A case report.
Malgorzata Szolkowska, Renata Langfort, Sebastian Winiarski, Jacek Zaremba, Monika Prochorec-Sobieszek, Piotr Jaskiewicz

Pol J Pathol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of treatment results in primary germ cell tumours with mediastinal location: own experience.
Dariusz M Kowalski, Magdalena Knetki-Wróblewska, Kinga Winiarczyk, Piotr Jaśkiewicz, Tadeusz Orłowski

Pneumonol Alergol Pol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of synaptophysin and chromogranin a expression in patients receiving palliative chemotherapy for advanced non-small-cell lung cancer.
Dariusz M Kowalski, Maciej Krzakowski, Piotr Jaśkiewicz, Włodzimierz Olszewski, Anna Janowicz-Żebrowska

Respiration· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland.
Dariusz M Kowalski, Maciej Krzakowski, Rodryg Ramlau, Piotr Jaskiewicz, Anna Janowicz-Żebrowska

Contemp Oncol (Pozn)· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Gefitinib in patients with advanced non-small-cell lung cancer].
Magdalena Knetki-Wróblewska, Dariusz M Kowalski, Katarzyna Zajda, Adam Płużański, Paweł Badurak

Pneumonol Alergol Pol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The qualification of docetaxel or erlotinib for second-line therapy should be based on clinical and molecular predictive factors.
Paweł Krawczyk, Dariusz M Kowalski, Kamila Wojas-Krawczyk, Radosław Mlak, Piotr Jaśkiewicz

Chemotherapy· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis